EUCTR2005-001192-34-ES进行中（未招募）不适用
Open pilot study phase IV to treat co infected HCV-HIV patients after their relapse with interferon therapy.Tratamiento de los pacientes con hepatitis crónica C infectados por el VIH que han recaído trás el tratamiento con terapias basadas en interferón:estudio piloto abierto. - PILOT NR
Vicente Soriano-Hospital Carlos III. Madrid0 个研究点目标入组 100 人开始时间: 2005年10月10日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Adults patients age from 18 to 65
- •anti HCV positive (ELISA)
- •RNA HCV positive
- •HIV positive
- •relapser patient to interferon therapy
- •lymfocytes CD4+ >200 cel/hl
- •anti HBsAg negative
- •compensate hepatopathy
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •pregnancy woman
- •HIV treatment with ddI
- •alcoholic hepatitis
研究者
相似试验
尚未招募
4 期
A community Observational Program for Hepatitis C treatmentCTRI/2017/01/007644Institute of Human Virology University of Maryland325
已完成
1 期
Phase I/II clinical trials using hepatitis C virus peptide with the combination therapy of interferon and ribavirin for the patient with chronic hepatitis Cchronic hepatitis CJPRN-UMIN000002601Ehime University Graduate School of Medicine, Department of Gastroenterology and Metabology20
已完成
4 期
Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and RibavirinHepatitis CNCT00207402Brooke Army Medical Center34
已完成
不适用
Prospective cohort study of HCV infection and the risk of developement of maligant lymphomahematopoietic malignancyJPRN-UMIN000003652Clinical Hematology Study Group of National Hospital Organization(CHSG-NHO)2,000
已完成
4 期
Pilot Treatment as Prevention for HCV Among Persons Who Actively Inject DrugsChronic Hepatitis CNCT02609893Phillip Coffin, MD, MIA31